ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Heiq Plc

Heiq Plc (HEIQ)

4.50
0.00
(0.00%)
Cerrado 04 Enero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
4.50
Postura de Compra
4.50
Postura de Venta
5.50
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
1.00 Rango de 52 semanas 15.95
Capitalización de Mercado [m]
Precio Anterior
4.50
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
811,563
Acciones en circulación
168,540,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.36
Beneficio por acción (BPA)
-0.12
turnover
62.32M
Beneficio neto
-20.84M

Acerca de Heiq Plc

Sector
Finance Services
Industria
Finance Services
Sitio web
Sede
London, Gbr
Fundado
-
Heiq Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEIQ. The last closing price for Heiq was 4.50p. Over the last year, Heiq shares have traded in a share price range of 1.00p to 15.95p.

Heiq currently has 168,540,000 shares in issue. The market capitalisation of Heiq is £7.58 million. Heiq has a price to earnings ratio (PE ratio) of -0.36.

HEIQ Últimas noticias

London Stock Exchange Notice Cancellation - HEIQ PLC

London Stock Exchange Notice 19 November 2024   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE   19/11/2024 - 08:00   At the request of the company the following...

HeiQ PLC Director/PDMR Shareholding

HeiQ PLC 18 November 2024   18 November 2024   HeiQ Plc ("HeiQ" or "the Company") Director / PDMR Dealing HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene...

HeiQ plans capital raise to support "ambitious" scale-up

HeiQ PLC on Thursday announced a potential open offer to help fund its venture scale-up plans, ahead of its scheduled ...

HeiQ PLC Update on Delisting and Potential Capital Raise

HeiQ PLC 14 November 2024   14 November 2024   HeiQ Plc ("HeiQ" or "the Company")   Update on Delisting and Potential Capital Raise Further to the announcement on 22 October 2024 regarding...

HeiQ PLC Notice of AGM

HeiQ PLC 31 October 2024   31 October 2024   HeiQ Plc ("HeiQ" or "the Company") Notice of Annual General Meeting   HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene...

HeiQ PLC Results for 18-month period ended 30 June 2024

HeiQ PLC 31 October 2024   31 October 2024  HeiQ Plc ("HeiQ" or "the Company") Results for 18-month period ended 30 June 2024   HeiQ Plc (LSE: HEIQ), a leading company in materials innovation...

HeiQ PLC Holding(s) in Company

HeiQ PLC 24 October 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...

HeiQ PLC Restructuring and Delisting

HeiQ PLC 22 October 2024   This announcement contains inside information   HeiQ Plc (the "Company") Restructuring and Delisting As detailed in the Company's trading update on 12 September...

HeiQ PLC Holding(s) in Company

HeiQ PLC 18 September 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

HeiQ PLC Director/PDMR Shareholding

HeiQ PLC 16 September 2024     16 September 2024 HeiQ Plc ("HeiQ" or the "Company" or the "Group") Director's Dealings HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1004.54.54.500DE
4004.54.54.500DE
12-1.3-22.41379310345.86.3918115633.03859516DE
26-6.95-60.698689956311.451215143654.15538583DE
52-8.9-66.417910447813.415.9513904036.07187083DE
156-87-95.081967213191.5108.75129285826.5744503DE
260-115-96.2343096234119.5247.5131282969.55956671DE

HEIQ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Heiq?
El precio actual de las acciones de Heiq es 4.50p
¿Cuántas acciones de Heiq están en circulación?
Heiq tiene 168,540,000 acciones en circulación
¿Cuál es la capitalización de mercado de Heiq?
La capitalización de mercado de Heiq es GBP 7.58M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Heiq?
Heiq ha negociado en un rango de 1.00p a 15.95p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Heiq?
El ratio precio/beneficio de Heiq es -0.36
¿Cuál es el ratio de efectivo a ventas de Heiq?
El ratio de efectivo a ventas de Heiq es 0.12
¿Cuál es la moneda de reporte de Heiq?
Heiq presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Heiq?
El último ingresos anual de Heiq es GBP 62.32M
¿Cuál es el último beneficio anual de Heiq?
El último beneficio anual de Heiq es GBP -20.84M
¿Cuál es la dirección registrada de Heiq?
La dirección registrada de Heiq es 15 WHITCHALL, LONDON, SW1A 2DD
¿Cuál es la dirección del sitio web de Heiq?
La dirección del sitio web de Heiq es www.heiq.com
¿En qué sector industrial opera Heiq?
Heiq opera en el sector FINANCE SERVICES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
benz280c benz280c 3 minutos hace
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 4 minutos hace
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 5 minutos hace
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 6 minutos hace
Probably
AVXL
HokieHead HokieHead 8 minutos hace
Wrong..
TWOH
HokieHead HokieHead 8 minutos hace
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 10 minutos hace
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 11 minutos hace
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 12 minutos hace
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 13 minutos hace
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 13 minutos hace
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 14 minutos hace
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 14 minutos hace
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 17 minutos hace
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 18 minutos hace
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 18 minutos hace
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 19 minutos hace
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 19 minutos hace
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME
Canna_Business Canna_Business 19 minutos hace
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
eb0783 eb0783 19 minutos hace
Thanks TJG. I never thought the subject needed any discussion......it was so obvious. Yet some feel they should denigrate the company for not saying it over and over.

Our Story
Affluence Corporation (OTC PINK:AFFU) was incorporated in 2008 and initially operated as a social net
AFFU
Canna_Business Canna_Business 20 minutos hace
$MRMD
MRMD
facts_matter14 facts_matter14 20 minutos hace
Let’s play a fantasy game and pretend there are “some” products available now.

Does this look like there are “some” products available now;

https://investorshub.advfn.com/uimage/uploads/2024/11/12/pmrdbIMG_5756.jpeg

https://investorshub.advfn.com/uimage/u
SRMX
lambchops lambchops 21 minutos hace
Do the holkie polky, turn yerself around...take a look in the mirror, that's what it's all a-bout.

Baaaaaaaaaaaaaaaaaa

LC

NFTM
NFTM
crescentmotor crescentmotor 21 minutos hace
The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

Maybe but I'm not convinced of that. When drugs are being considered for regulatory approval, I am always amazed at the huge effort put for by member
AVXL
demonsmith demonsmith 22 minutos hace
So nukk was trading at 0.0012 when are new ceo took control and brought it to Nasdaq from otc you half to be crazy to split know
TWOH